TrialClinical cancer research : an official journal of the American Association for Cancer Research2024

Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial.

Charles B Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.